These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3008302)

  • 1. [Acute polyradiculoneuropathy of Guillain-Barré. Critical review of potential etiopathogeneses].
    Guadagnino M; Petitto F
    Riv Neurol; 1985; 55(6):402-23. PubMed ID: 3008302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes.
    Goffette S; Jeanjean A; Pierret F; Peeters A; Sindic CJ
    Acta Neurol Belg; 1998 Dec; 98(4):322-6. PubMed ID: 9922819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology of the motor-sensory axonal Guillain-Barré syndrome.
    Griffin JW; Li CY; Ho TW; Tian M; Gao CY; Xue P; Mishu B; Cornblath DR; Macko C; McKhann GM; Asbury AK
    Ann Neurol; 1996 Jan; 39(1):17-28. PubMed ID: 8572662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effects of sera from Guillain-Barré subgroups: an electrophysiological and histological study on rat nerves.
    Oomes PG; van der Meché FG; Markus-Silvis L; Meulstee J; Kleyweg RP
    Muscle Nerve; 1991 Oct; 14(10):1013-20. PubMed ID: 1658645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part I.
    Hartung HP; Pollard JD; Harvey GK; Toyka KV
    Muscle Nerve; 1995 Feb; 18(2):137-53. PubMed ID: 7823972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome associated with cytomegalovirus infection.
    Hart IK; Kennedy PG
    Q J Med; 1988 May; 67(253):425-30. PubMed ID: 2851853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New aspects of the pathogenesis and therapy of Guillain-Barré syndrome and chronic polyneuritis].
    Hartung HP; Heininger K; Toyka KV
    Nervenarzt; 1990 Apr; 61(4):197-207. PubMed ID: 2191228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inflammatory demyelinating diseases if the peripheral nervous system: immunological concepts and experimental models].
    Vass K; Lassmann H
    Wien Klin Wochenschr Suppl; 1991; 190():13-6. PubMed ID: 1771901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guillain-Barré syndrome associated with cytomegalovirus infection after kidney transplantation].
    Lloveras JJ; Larrue V; Delisle MB; Tack I; Icart J; Dupré C; Ton That H; Durand D; Suc JM
    Presse Med; 1994 Jun; 23(21):976-8. PubMed ID: 7937644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunopathology of Guillain-Barré syndrome.
    Saida K
    Curr Opin Neurol; 1996 Oct; 9(5):329-33. PubMed ID: 8894406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders.
    Enders U; Karch H; Toyka KV; Michels M; Zielasek J; Pette M; Heesemann J; Hartung HP
    Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain-Barré syndrome with cytomegalovirus infection of peripheral nerves.
    Bishopric G; Bruner J; Butler J
    Arch Pathol Lab Med; 1985 Dec; 109(12):1106-8. PubMed ID: 3000318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
    Oomes PG; Jacobs BC; Hazenberg MP; Bänffer JR; van der Meché FG
    Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barre syndrome and Campylobacter jejuni infection. A study on the etiological characteristics of Guillain-Barre syndrome in China.
    Yuan JM; Tang J; Chen QT; Xiao L; Hao HJ; Jia ZD; Huang QH; Liu XZ
    Chin Med J (Engl); 1993 Nov; 106(11):845-7. PubMed ID: 8143497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class II antigen expression and inflammatory cells in the Guillain-Barré syndrome.
    Pollard JD; Baverstock J; McLeod JG
    Ann Neurol; 1987 Apr; 21(4):337-41. PubMed ID: 3555282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome after heart transplantation.
    Baldwin RT; Pierce RR; Frazier OH
    J Heart Lung Transplant; 1992; 11(4 Pt 1):817-9. PubMed ID: 1323331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Landry-Guillain-Barré-Strohl syndrome in pregnancy. A report of two cases.
    May SE; Caudle MR; Kleinman GE
    J Reprod Med; 1989 Aug; 34(8):550-2. PubMed ID: 2553960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a patient with GVHD after allogeneic BMT.
    Hagensee ME; Benyunes M; Miller JA; Spach DH
    Bone Marrow Transplant; 1994 Mar; 13(3):349-51. PubMed ID: 8199580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
    Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP
    Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guillain-Barré syndrome: development of concepts].
    Serratrice G
    Rev Neurol (Paris); 1996 May; 152(5):333-8. PubMed ID: 8881425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.